American Cancer Society Trivializes Cancer Risks: Blatant Conflicts of Interest

Print

The May 6 report by the President's Cancer Panel is well-documented. It warns of scientific evidence on avoidable causes of cancer from exposure to carcinogens in air, water, consumer products, and the workplace. It also warns of hormonal risks from exposure to Bisphenol-A (BPA) and other toxic plastic contaminants, says Samuel S. Epstein, M.D., Chairman of the Cancer Prevention Coalition (CPC).

Concerns on avoidable causes of cancer have been summarized in a January 23, 2009 Cancer Prevention Coalition press release, endorsed by 20 leading scientists and public policy experts, who urged that President Obama's cancer plan should prioritize prevention. These concerns were further detailed in a June 15, 2009 press release. Warnings of the risks of BPA are also detailed in a May 6, 2010 CPC release.

Some of the more startling realities in the National Cancer Institute's (NCI) and the "non-profit" American Cancer Society's (ACS) long-standing failure to prevent a very wide range of cancers are illustrated by their soaring increases from 1975 to 2005.

These include:

Criticisms by the American Cancer Society that the President's Cancer Panel's report exaggerates avoidable cancer risks, reflect reckless indifference, besides narrow self-interest, warns Dr. Epstein.

In 1993, the nation's leading charity watch dog, The Chronicle of Philanthropy, warned against the transfer of money from the public purse to the private hands of the American Cancer Society. The Chronicle also warned that, "The ACS is more interested in accumulating wealth than saving lives."

These warnings are fully supported by the track record of the ACS for well over the last four decades.

The ACS's indifference to cancer prevention also reflects major conflicts of interest with regard to public relations, Dr. Epstein emphasizes.

PUBLIC RELATIONS

INDUSTRY FUNDING

The ACS's indifference to cancer prevention reflects major industry funding. ACS has received contributions in excess of $100,000 from a wide range of "Excalibur Donors," many of whom continue to manufacture carcinogenic products, points out Dr. Epstein.

These include:

Nevertheless, warns Dr. Epstein, in spite of this long-standing track record of flagrant conflicts of interest, as reported in the December 8, 2009 New York Times, the ACS responded that it "holds itself to the highest standards of transparency and public accountability."



Samuel S. Epstein, M.D. is professor emeritus of Environmental and Occupational Medicine at the University of Illinois at Chicago School of Public Health; Chairman of the Cancer Prevention Coalition; The 2005 Albert Schweitzer Golden Grand Medalist for International Contributions to Cancer Prevention; and author of over 270 scientific articles and 20 books on the causes and prevention of cancer, including the groundbreaking The Politics of Cancer (1979), Cancer-Gate: How To Win The Losing Cancer War (2005, Baywood Publishing), and Toxic Beauty (2009, BenBella Books).